Is Skin Botox Effective? Evidence and Points to Check

Key summary. Skin Botox (also called micro-Botox or meso-Botox) is a procedure in which botulinum toxin is divided into very small amounts and injected into the shallow layers of the skin, rather than into muscle, to improve oil production, pores, and skin texture. In a combined analysis of 10 studies (153 participants), sebum production, pore size, skin texture, redness, and fine lines all moved consistently in the direction of improvement, but the research has not yet accumulated enough to say the effect is "firmly proven." This analysis was corrected after publication when data errors were pointed out; the direction of the conclusion was maintained, but the exact figures differed from the original.

What this article covers

• How it differs from regular Botox, and the effects actually confirmed in research
• Why "the direction is positive" and "firmly proven" are not the same statement
• The originally approved uses of the products used

Key points

1. What it is: A technique that injects botulinum toxin at multiple points in the shallow layers of the skin rather than into muscle, suppressing oil production by reducing the nerve signals that stimulate the sebaceous glands.
2. For whom: It is performed for people who want to improve oil production, pores, redness, and fine lines, but this procedure is an off-label use of Botox, outside its approved range in Korea.
3. Order of checking: the product name and approved use → the level of the evidence presented to you → the practitioner's qualifications → information on side effects.

01What exactly is skin Botox?

Regular Botox is injected into muscle to reduce muscle movement and smooth wrinkles. Skin Botox (also called micro-Botox, meso-Botox, or baby Botox) differs in that it injects very small amounts at many points in the shallow layers of the skin, and its target is not muscle but the sebaceous glands, pores, and skin texture. It reduces the nerve signals that stimulate the sebaceous glands to suppress oil production, and it calms inflammatory responses to reduce redness as well.

Botulinum toxin products from several brands are used for this procedure, including Botox, Dysport, Xeomin, Juvederm's Botulax-type products and others such as Jeuveau and Botulax. The indications for which Botox has been approved in Korea are glabellar lines, crow's feet, eyelid spasm, strabismus, cervical dystonia, post-stroke arm spasticity, underarm hyperhidrosis, chronic migraine, and bladder dysfunction, all of which target muscles or sweat glands. Improving sebaceous glands, pores, or skin texture is not within this approved range, so skin Botox, which is injected in small divided amounts into the shallow layers of the skin to address oil and pores, is an off-label procedure used outside the approved range.

02How is it actually performed?

Skin Botox varies considerably from clinic to clinic. In the 10 studies reviewed here, the dose used for one half of the face ranged widely between studies, from 5 units to 30 units, and the dilution ratio also varied, from mixing 100 units of Botox into 10mL of saline to more concentrated mixtures. The number of injection points per session also varied, from 5 to 30. In other words, even when the name "skin Botox" is the same, the dose, dilution concentration, and number of injection points actually used may differ from clinic to clinic. It is a good idea to ask for specific information on these three things at the consultation.

This research did not report whether anesthesia was used or how long the procedure takes. Because the procedure involves injecting at many points in the shallow layers of the skin, some clinics use numbing cream and others do not.

03How large were the effects confirmed in the research?

In the table, "clearly" means that a change was observed that is unlikely to be explained by chance. Except for skin hydration (moisture), all the other 6 items passed this standard. However, "a clear change was observed" and "the effect has been firmly proven" are not the same statement. The researchers also separately calculated whether the accumulated research was large enough to draw a conclusion. For all 7 items, the change itself can be considered not due to chance, but the research has not accumulated to the level where one can say it is "so certain that no further study is needed." The direction of the studies so far is consistently positive, but this means the research has not accumulated enough to completely rule out the possibility of chance.

04How quickly does the effect appear, and how long does it last?

Of the 10 studies included in this meta-analysis, none measured precisely when the effect appears or how long it lasts. However, one retrospective study cited in the meta-analysis observed that changes began within 1 week of the procedure, were greatest at week 4, and lasted up to week 12 (about 3 months). Keep in mind that this is an observation from one of those studies, not a shared result across all 10 studies in the meta-analysis.

05How reliable is this study?

This meta-analysis pooled 10 studies from 8 countries around the world (the UK, India, Germany, the US, Greece, Italy, Georgia, Australia, China, Brazil, Canada, Singapore, and others). The 153 participants had an average age of 41 years, and 92.1% were women. The products used were also varied, spanning 7 brands.

The limitations the authors themselves acknowledge are clear. Most studies had few participants, doses and dilution concentrations varied widely between studies and were hard to compare directly, and the measures used to assess the effect also differed between studies, so the results may have been skewed in one direction. The authors also stated that "being statistically significant does not mean a benefit that patients would notice in real clinical practice".

This study is also a case in which data errors were actually pointed out and corrected after publication. In 2025, other researchers pointed out that control-group values had been extracted incorrectly from some of the studies used for the sebum production and pore size outcomes, and the original authors acknowledged this and recalculated. As a result, a clear change was still found for both outcomes, but the exact figures differed from those first published. As for funding, 3 of the 10 studies were supported by a botulinum toxin manufacturer, and the results did not change much when the analysis was recalculated without those 3 studies.

06What to check before the procedure

07Choosing by situation

• If your goal is improving sebum and pores → Discuss it with the understanding that the evidence points in a positive direction but is not yet conclusive
• If you expect better skin hydration (moisture) → This study did not find a significant improvement
• Do not confuse it with regular botulinum toxin (wrinkle treatment targeting muscles) → The purpose, injection depth, and approved use differ, so make the distinction clear during your consultation

08Common misconceptions

"It was significant in the meta-analysis, so the effect is definitely proven" — As seen above, being statistically significant is a different standard from being sufficiently proven.

"This paper's figures were accurate from the start" — Control-group values from some studies were extracted incorrectly and recalculated. However, significance was maintained even after the recalculation.

"Skin botox is also used for its original approved purpose, just like botulinum toxin" — No. The approved uses of botulinum toxin cover muscles and sweat glands, and skin botox, which is injected into the shallow layers of the skin to address sebum and pores, is an off-label procedure used outside this scope.

09In summary

The evidence for skin botox is building in the direction of effectiveness, but it has not yet reached the stage where it can be stated as "definitely proven." Clear improvement was observed in all 5 outcomes (sebum, pores, skin texture, redness, and fine lines), with skin hydration as the only exception. However, even the leading study in this field has a history of data errors being pointed out and corrected, and the dose and dilution concentration used also vary from clinic to clinic. You should also be clear that this procedure is off-label, used outside the approved uses of botulinum toxin in Korea. Regular botulinum toxin, which is injected into muscles even though it contains the same active ingredient, differs in purpose and in how the evidence is structured.

10Frequently Asked Questions

How is skin Botox different from regular Botox?

The injection depth and the goal are different. Regular Botox is injected into muscle to reduce movement. Skin Botox is injected in small amounts into the shallow layers of the skin, targeting oil glands, pores, and skin texture.

Has the effect of skin Botox been firmly proven?

It is too early to say that. Clear improvements were observed in oil production, pores, skin texture, redness, and fine lines, but the research has not built up to the point where one can say "it is certain, and no further study is needed".

Is skin Botox a procedure that has formal approval as a Botox treatment?

No. Botox's approved indications in Korea are things like frown lines between the eyebrows, crow's feet, and excessive underarm sweating, which target muscles and sweat glands. Improving oil production and pores is not included. Skin Botox is an off-label procedure used outside this scope.

Is skin Botox also effective for skin hydration?

No. In this study, skin moisture (hydration) did not show a significant improvement. Good results in other measures are not evidence that hydration also improves.

Is the research in this field trustworthy?

It is hard to say that it is fully so. A data error was pointed out in the main study and it has a history of being corrected, and the authors themselves stated that the number of participants was small and that doses and measurement criteria differed between studies, making direct comparison difficult.

11Pre-consultation checklist

• □ I was told that this procedure is off-label
• □ I was given specific information about the dose, the dilution concentration, and the number of injection points
• □ I was told clearly whether the evidence presented is at the level of "significant" or "sufficiently proven"
• □ I confirmed which medical professional will actually perform the procedure and their qualifications
• □ I received written information about side effects and the procedure for handling them

12Glossary

• RCT (randomized controlled trial): A study method in which participants are randomly divided into groups for comparison, with relatively high reliability.
• Controlled study: A study that includes a separate comparison group (control group) alongside the group that received the procedure. Without a control group, it is hard to tell whether an improvement was caused by the procedure or by something else.
• Meta-analysis: An analysis method that statistically combines the results of several individual studies to reach a single conclusion.
• p-value: A number indicating the probability that the difference between two groups arose purely by chance. A value smaller than 0.05 is usually taken to mean "it is hard to attribute to chance (statistically significant)."
• Off-label: Use of a drug for a purpose other than the one for which it was originally approved.

13Sources and verification date

• PMC11343530 — 2026-09-19 verified (2026-10-02 re-verified). Systematic review, meta-analysis, and trial sequential analysis (TSA) of intradermal botulinum toxin, 10 studies (RCT 5, cohort 5), 153 participants (8 countries). Of the 10 studies, 3 were supported by manufacturers, and many of the authors reported conflicts of interest as consultants to botulinum toxin manufacturers and as paid speakers. Treatment methods (dose, dilution, number of injection points) and the limitations the authors themselves described were verified directly.
• PMC11723705 — 2026-09-19 verified. A letter pointing out data extraction errors in the above meta-analysis.
• PMC11888971 — 2026-09-19 verified. The original authors' recalculation and reply, acknowledging the errors and presenting corrected figures.
• MFDS Integrated Drug Information System, Botox Inj. product information, verified on 2026-10-02. Confirmed the approved domestic indications (frown lines between the eyebrows, crow's feet, blepharospasm, strabismus, cervical dystonia, upper limb spasticity, excessive underarm sweating, chronic migraine, bladder dysfunction), and confirmed that indications for improving oil production, pores, and skin texture are not included.
• The studies above are materials for understanding how the procedure works and the state of the evidence, and they do not guarantee any particular clinic, practitioner, or result.

14Editorial responsibility and interests

• Written by: Korea Beauty Report editorial team · Editorial responsibility: Korea Beauty Report editorial team
• Review scope: The editorial team prepared this content from published research and public data. It was not separately reviewed by a medical professional and does not replace individual diagnosis or treatment.
• Interests: No clinic with a contract or advertising relationship is involved in this article
• First published: 2026-10-02, last source check: 2026-10-02